Gene · 580
Papers4,139
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 4,139
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pro-tumourigenic effects of DCAF13 on the progression of colorectal cancer. | Oncol Lett | 2026 | 41797888 | PubTator, text mining | PubMed |
| Investigating the association of NBN gene polymorphisms with multiple cancers through statistical meta-analysis and bioinformatics insights. | Biol Methods Protoc | 2026 | 41797823 | PubTator, text mining | PubMed |
| Integrating breast tumour homologous recombination deficiency status to aid germline BRCA1 and BRCA2 variant classification. | EBioMedicine | 2026 | 41797047 | PubTator, text mining | PubMed |
| Factors Associated With Inaccurate Recall of Inherited Cancer Genetic Test Results Among Individuals With Germline Pathogenic Variants. | Cancer Med | 2026 | 41795147 | PubTator, text mining | PubMed |
| Native chromatome profiling reveals hundreds of metabolic enzymes in the nucleus across tissues. | Nat Commun | 2026 | 41792114 | PubTator, text mining | PubMed |
| Identification of Genetic Variants Among Breast Cancer Patients and At-Risk Individuals: A Cohort Study in Sri Lanka. | Breast Cancer (Auckl) | 2026 | 41783385 | PubTator, text mining | PubMed |
| Assessing Large Language Models for Early Article Identification in Otolaryngology-Head and Neck Surgery Systematic Reviews. | Health Care Sci | 2026 | 41767168 | PubTator, text mining | PubMed |
| EpGAT: integrating epigenetics and 3D genome structure to predict alternative splicing and polyadenylation. | Brief Bioinform | 2026 | 41766646 | PubTator, text mining | PubMed |
| BPHL promotes TNBC stemness by resolving R-loops via POLR2A lactylation inhibition and BARD1-mediated ubiquitination. | Cancer Lett | 2026 | 41765360 | PubTator, text mining | PubMed |
| Paired-Box (PAX) Gene Signatures as a Biomarker of Breast Cancer Progression. | Int J Mol Sci | 2026 | 41752124 | PubTator, text mining | PubMed |
| PARP Inhibitors Combined with Abiraterone Overcome Resistance in Metastatic Castration-Resistant Prostate Cancer Independently of Androgen Receptor. | Cancers (Basel) | 2026 | 41749814 | PubTator, text mining | PubMed |
| Poly(ADP-ribose) polymerase (PARP) inhibitors in cardiovascular, and cerebrovascular diseases: mechanisms, current trends and challenge for clinical translation. | PeerJ | 2026 | 41736752 | PubTator, text mining | PubMed |
| DNA topological regulation in RNA polymerase II transcription. | Cell Mol Biol Lett | 2026 | 41735852 | PubTator, text mining | PubMed |
| Role of laser therapy in enhancing chemotherapy efficiency in breast cancer: low level laser therapy, photochemotherapy, and photodynamic therapy as promising treatments. | Lasers Med Sci | 2026 | 41731105 | PubTator, text mining | PubMed |
| Primary pulmonary histiocytic sarcoma with CNS metastasis: a case report and molecular profiling insights. | Front Oncol | 2026 | 41727642 | PubTator, text mining | PubMed |
| Quantifying rate-limiting genetic variation in breast and ovarian tumourigenesis. | EBioMedicine | 2026 | 41724111 | PubTator, text mining | PubMed |
| Cosegregation analysis following an excellent response to olaparib in a pancreatic cancer patient carrier of BRCA2:c.7892 T > C variant enables its reclassification from VUS to pathogenic. | BJC Rep | 2026 | 41699384 | PubTator, text mining | PubMed |
| Homologous recombination deficiency in primary ER-positive and HER2-negative breast cancer. | Commun Med (Lond) | 2026 | 41699108 | PubTator, text mining | PubMed |
| Discovering Hereditary Risk Through Surveillance: A Prospective Genetic Analysis of Individuals With Familial Pancreatic Cancer. | United European Gastroenterol J | 2026 | 41691430 | PubTator, text mining | PubMed |
| The Contribution of Genetic Modifiers to Ovarian Cancer Risk in BRCA1 and BRCA2 Pathogenic Variant Carriers. | Cancers (Basel) | 2026 | 41681824 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/580/papers?page=4